A detailed history of Eubel Brady & Suttman Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Eubel Brady & Suttman Asset Management Inc holds 135,193 shares of JNJ stock, worth $21 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
135,193
Previous 135,532 0.25%
Holding current value
$21 Million
Previous $19.8 Million 10.6%
% of portfolio
2.86%
Previous 2.87%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $49,317 - $56,741
-339 Reduced 0.25%
135,193 $21.9 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $4.14 Million - $4.52 Million
28,660 Added 26.82%
135,532 $19.8 Million
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $292,434 - $306,602
1,884 Added 1.79%
106,872 $16.9 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $10,337 - $11,280
71 Added 0.07%
104,988 $16.5 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $7.08 Million - $7.93 Million
-45,468 Reduced 30.23%
104,917 $16.3 Million
Q2 2023

Aug 25, 2023

BUY
$154.35 - $166.11 $321,511 - $346,007
2,083 Added 1.4%
150,385 $24.9 Million
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $745,431 - $889,583
4,935 Added 3.44%
148,302 $23 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $258,562 - $290,181
1,614 Added 1.14%
143,367 $25.3 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $1.08 Million - $1.2 Million
6,701 Added 4.96%
141,753 $23.2 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $62,062 - $68,637
-369 Reduced 0.27%
135,052 $24 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $813,155 - $923,451
5,142 Added 3.95%
135,421 $24 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $524,548 - $582,005
3,364 Added 2.65%
130,279 $22.3 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $825,265 - $917,091
5,110 Added 4.2%
126,915 $20.5 Million
Q2 2021

Aug 17, 2021

SELL
$159.48 - $171.07 $19.4 Million - $20.8 Million
-121,805 Reduced 50.0%
121,805 $20 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $18.7 Million - $20.9 Million
122,350 Added 100.9%
243,610 $40 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $354,429 - $406,827
-2,585 Reduced 2.09%
121,260 $19.1 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $3,369 - $3,691
24 Added 0.02%
123,845 $18.4 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $215,499 - $260,168
-1,673 Reduced 1.33%
123,821 $17.4 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $178,379 - $247,153
1,605 Added 1.3%
125,494 $16.5 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $5,482 - $6,296
43 Added 0.03%
123,889 $18.1 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $146,373 - $163,887
-1,153 Reduced 0.92%
123,846 $16 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $87,739 - $96,496
-669 Reduced 0.53%
124,999 $17.4 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $93,912 - $104,423
747 Added 0.6%
125,668 $17.6 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $106,502 - $128,177
867 Added 0.7%
124,921 $16.1 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $851 - $1,000
7 Added 0.01%
124,054 $17.1 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $118,683 - $130,969
-994 Reduced 0.79%
124,047 $15.1 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $183,771 - $217,617
-1,469 Reduced 1.16%
125,041 $16 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $757,139 - $828,687
-5,770 Reduced 4.36%
126,510 $17.7 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $338,046 - $353,477
-2,611 Reduced 1.94%
132,280 $17.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
134,891
134,891 $17.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.